Uterine scarring breakthrough? 5,000-Woman study tests new surgery and stent
NCT ID NCT07421908
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This large study of 5,000 women with intrauterine adhesions (scarring inside the womb) aims to improve diagnosis and treatment. Researchers will test a new approach that combines 3D ultrasound, a special 'cold knife' surgery, and a silicone uterine stent to prevent scarring from returning. The goal is to see if this new care model helps more women achieve pregnancy within two years after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cold knife plowing surgery and uterine cavity stent
What this could lead to
If successful, this could lead to a standardized, more effective treatment approach for intrauterine adhesions, potentially improving pregnancy rates for affected women.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may take years and might not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAUTERINE ADHESION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Third Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••